Cure 250 Children with Burkitt Lymphoma in Africa

by The International Network for Cancer Treatment and Research (INCTR)
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Jan 22, 2021

Kalum's Journey for Hope and Cure

Kalum's Excited and Ready to Go Home!
Kalum's Excited and Ready to Go Home!

Kalum, aged ten, was brought to St. Mary’s Hospital Lacor in Gulu, Uganda by her father in late September of 2020. They travelled 200 kilometers from their village in the Moyo District to come to our hospital. Her mother remained at home to continue her work as a peasant farmer and to care for Kalum’s seven siblings.

Approximately six weeks prior to admission, Kalum’s father reported that she had a tooth extraction and soon afterwards developed rapidly progressive and painful swelling of her left jaw. Upon examination, we noted that the left side of her face was grossly deformed and that she had a mass protruding from the inside of her mouth. Her abdomen was mildly distended and a mass in the right upper abdominal quadrant was palpable and very tender. She had no other clinical signs of disease.

We performed routine laboratory work as well as other diagnostic tests, including an abdominal ultrasound. The ultrasound showed that she had multiple solid masses in her liver as well as a mass in her right kidney. Her other tests were negative. A biopsy of her jaw mass was taken. The results of the biopsy confirmed that she had Burkitt lymphoma.

Based upon the results of the investigations, it was decided to treat Kalum according to the high-risk arm of the INCTR treatment protocol for Burkitt lymphoma – meaning that she would receive a total of six cycles of chemotherapy with intrathecal therapy to prevent spread of disease to her central nervous system. She was started on treatment as soon as possible.  

After two cycles of chemotherapy, she had an excellent response. There was complete resolution of all masses in her abdomen as well as her jaw mass. She recently finished her sixth and last cycle of treatment and tests performed at this time showed that she was in complete remission.

Because treatment cycles for Burkitt lymphoma are given every two weeks and any unnecessary delays in treatment for this particularly aggressive cancer – such a discharge to a home far away from the hospital - can have negative consequences, it was decided that Kalum needed to remain with us for the duration of her treatment. Once she finished all planned therapy, she was very excited to go back home to see her siblings after her long hospital stay!  

Your donations to this project support the costs of treatment and gives children with Burkitt lymphoma the opportunity and hope for long-term cure. Your donations also help to support the costs of transportation so that children and their parents can reach a hospital capable of treating this very curable cancer. Transportation costs are all too often unaffordable for families like Kalum’s. Thank you again for generosity!

Share on Twitter Share on Facebook
Comments:

About Project Reports

Project Reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you will get an e-mail when this project posts a report. You can also subscribe for reports via e-mail without donating.

Get Reports via Email

We'll only email you new reports and updates about this project.

Project Leader:
Melissa Adde
Brussels, Brussels Belgium
$107,020 raised of $115,000 goal
 
817 donations
$7,980 to go
Donate Now
lock
Donating through GlobalGiving is safe, secure, and easy with many payment options to choose from. View other ways to donate

The International Network for Cancer Treatment and Research (INCTR) has earned this recognition on GlobalGiving:
Add Project to Favorites

Help raise money!

Support this important cause by creating a personalized fundraising page.

Start a Fundraiser

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Sign up for the GlobalGiving Newsletter

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.